Publications | PubMed=4122458; DOI=10.1002/ijc.2910100108 George Klein, Laszlo Dombos, Balwant Gothoskar; Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus. Int. J. Cancer 10:44-57(1972) PubMed=4347031; DOI=10.1093/jnci/48.1.87 John F. Hewetson, Balwant Gothoskar, George Klein; Radioiodine-labeled antibody test for the detection of membrane antigens associated with Epstein-Barr virus. J. Natl. Cancer Inst. 48:87-94(1972) PubMed=4364259; DOI=10.1002/ijc.2910110210 George Klein, Laszlo Dombos; Relationship between the sensitivity of EBV-carrying lymphoblastoid lines to superinfection and the inducibility of the resident viral genome. Int. J. Cancer 11:327-337(1973) PubMed=7316467; DOI=10.1111/j.1469-1809.1980.tb00953.x Susan Povey, Stephen Jeremiah, Elizabeth Arthur, Michael Steel, George Klein; Differences in genetic stability between human cell lines from patients with and without lymphoreticular malignancy. Ann. Hum. Genet. 44:119-133(1980) PubMed=6811418; DOI=10.1016/S0171-2985(11)80031-8 Gad Spira, Norio Koide, Pierre Aman, Rosalie Ber, George Klein; Truncated mu chain in a Burkitt lymphoma line (P3HR-1) and its fate in various hemapoietic somatic cell hybrids. Immunobiology 162:199-209(1982) PubMed=6231253; DOI=10.1002/ijc.2910330407 Barbro Ehlin-Henriksson, George Klein; Distinction between Burkitt lymphoma subgroups by monoclonal antibodies: relationships between antigen expression and type of chromosomal translocation. Int. J. Cancer 33:459-463(1984) PubMed=3026973; DOI=10.1002/ijc.2910390215 Barbro Ehlin-Henriksson, Agneta Manneborg-Sandlund, George Klein; Expression of B-cell-specific markers in different Burkitt lymphoma subgroups. Int. J. Cancer 39:211-218(1987) PubMed=8547074; DOI=10.1111/j.1365-2141.1995.tb05302.x Reiner Siebert, Christoph P. Willers, Alexander Schramm, Alexander Fossa, Irina M. Gana Dresen, Michael J. Uppenkamp, Mohammad Resa Nowrousian, Siegfried Seeber, Bertram Opalka; Homozygous loss of the MTS1/p16 and MTS2/p15 genes in lymphoma and lymphoblastic leukaemia cell lines. Br. J. Haematol. 91:350-354(1995) PubMed=9473234; DOI=10.1182/blood.V91.5.1680 Ulf Klangby, Ismail Okan, Kristinn Petur Magnusson, Martin Wendland, Peter Lind, Klas G. Wiman; p16/INK4a and p15/INK4b gene methylation and absence of p16/INK4a mRNA and protein expression in Burkitt's lymphoma. Blood 91:1680-1687(1998) PubMed=16051863; DOI=10.1128/JVI.79.16.10709-10717.2005; PMCID=PMC1182620 Gemma L. Kelly, Anne E. Milner, Rosemary J. Tierney, Debbie S.G. Croom-Carter, Markus Altmann, Wolfgang Hammerschmidt, Andrew I. Bell, Alan Bernard Rickinson; Epstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis. J. Virol. 79:10709-10717(2005) PubMed=24590883; DOI=10.1002/gcc.22161 Eva-Maria Murga Penas, Georgia Schilling, Petra Behrmann, Marianne Klokow, Eik Vettorazzi, Carsten Bokemeyer, Judith Dierlamm; Comprehensive cytogenetic and molecular cytogenetic analysis of 44 Burkitt lymphoma cell lines: secondary chromosomal changes characterization, karyotypic evolution, and comparison with primary samples. Genes Chromosomes Cancer 53:497-515(2014) PubMed=28960205; DOI=10.1038/cdd.2017.150; PMCID=PMC5762840 Leah Fitzsimmons, Andrew J. Boyce, Wen-Bin Wei, Catherine Chang, Debbie S.G. Croom-Carter, Rosemary J. Tierney, Marco J. Herold, Andrew I. Bell, Andreas Strasser, Gemma L. Kelly, Martin Rowe; Coordinated repression of BIM and PUMA by Epstein-Barr virus latent genes maintains the survival of Burkitt lymphoma cells. Cell Death Differ. 25:241-254(2018) |